You just read:

Statement from Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the agency's ongoing efforts to resolve safety issue with ARB medications

News provided by

U.S. Food and Drug Administration

Aug 28, 2019, 09:33 ET